Stock Analysis on Net

RTX Corp. (NYSE:RTX)

Income Statement 
Quarterly Data

The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

RTX Corp., consolidated income statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 3, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Products sales 15,765 17,765 16,264 15,551 14,591 16,039 14,708 14,562 14,303 14,758 8,615 13,411 12,787 13,897 12,756 12,258 11,862 13,096 12,331 12,179 11,664
Services sales 6,311 6,473 6,214 6,030 5,715 5,584 5,381 5,159 5,002 5,169 4,849 4,904 4,427 4,196 4,195 4,056 3,854 3,948 3,882 3,701 3,587
Net sales 22,076 24,238 22,478 21,581 20,306 21,623 20,089 19,721 19,305 19,927 13,464 18,315 17,214 18,093 16,951 16,314 15,716 17,044 16,213 15,880 15,251
Cost of sales, products (13,000) (14,915) (13,593) (12,989) (12,283) (13,591) (12,336) (12,625) (12,216) (12,347) (9,289) (11,089) (10,700) (11,574) (10,493) (10,040) (9,820) (10,828) (10,296) (9,997) (9,974)
Cost of sales, services (4,482) (4,606) (4,305) (4,216) (3,907) (3,797) (3,719) (3,516) (3,528) (3,571) (3,461) (3,429) (2,945) (2,952) (2,971) (2,816) (2,740) (2,788) (2,793) (2,658) (2,563)
Cost of sales (17,482) (19,521) (17,898) (17,205) (16,190) (17,388) (16,055) (16,141) (15,744) (15,918) (12,750) (14,518) (13,645) (14,526) (13,464) (12,856) (12,560) (13,616) (13,089) (12,655) (12,537)
Gross margin 4,594 4,717 4,580 4,376 4,116 4,235 4,034 3,580 3,561 4,009 714 3,797 3,569 3,567 3,487 3,458 3,156 3,428 3,124 3,225 2,714
Research and development (627) (789) (684) (697) (637) (808) (751) (706) (669) (757) (712) (729) (607) (716) (662) (698) (635) (810) (676) (657) (589)
Selling, general, and administrative (1,476) (1,638) (1,436) (1,573) (1,448) (1,574) (1,389) (1,449) (1,394) (1,375) (1,401) (1,635) (1,398) (1,379) (1,391) (1,424) (1,469) (1,407) (1,229) (1,368) (1,220)
Other income (expense), net 64 306 63 40 4 258 134 (896) 372 (30) 3 25 88 29 46 17 28 109 124 82 108
Operating profit (loss) 2,555 2,596 2,523 2,146 2,035 2,111 2,028 529 1,870 1,847 (1,396) 1,458 1,652 1,501 1,480 1,353 1,080 1,320 1,343 1,282 1,013
Non-service pension income 355 101 364 351 366 384 374 374 386 446 443 447 444 467 468 474 480 472 491 490 491
Debt extinguishment costs (649)
Interest expense, net (390) (400) (449) (457) (443) (486) (496) (475) (405) (488) (369) (333) (315) (318) (311) (329) (318) (276) (358) (342) (346)
Non-operating income (expense), net (35) (299) (85) (106) (77) (102) (122) (101) (19) (42) 74 114 129 149 157 145 162 (453) 133 148 145
Income (loss) from continuing operations before income taxes 2,520 2,297 2,438 2,040 1,958 2,009 1,906 428 1,851 1,805 (1,322) 1,572 1,781 1,650 1,637 1,498 1,242 867 1,476 1,430 1,158
Income tax (expense) benefit (363) (584) (432) (315) (333) (449) (371) (253) (108) (332) 389 (213) (300) (182) (242) (160) (116) (96) (3) (342) (345)
Net income (loss) from continuing operations 2,157 1,713 2,006 1,725 1,625 1,560 1,535 175 1,743 1,473 (933) 1,359 1,481 1,468 1,395 1,338 1,126 771 1,473 1,088 813
Net loss from discontinued operations (19) 1 (7) (8) (19)
Net income (loss) 2,157 1,713 2,006 1,725 1,625 1,560 1,535 175 1,743 1,473 (933) 1,359 1,481 1,468 1,395 1,338 1,107 772 1,466 1,080 794
Noncontrolling interest in subsidiaries’ earnings (98) (91) (88) (68) (90) (78) (63) (64) (34) (47) (51) (32) (55) (46) (8) (34) (23) (86) (73) (48) (41)
Net income (loss) attributable to common shareowners 2,059 1,622 1,918 1,657 1,535 1,482 1,472 111 1,709 1,426 (984) 1,327 1,426 1,422 1,387 1,304 1,084 686 1,393 1,032 753

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-03), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


Revenue exhibits a sustained long-term growth trajectory, with net sales increasing from 15,251 million USD in March 2021 to 22,076 million USD by March 2026. This growth is characterized by a steady rise in both product and service streams, despite a significant temporary contraction in the third quarter of 2023, where net sales fell to 13,464 million USD before recovering strongly in subsequent periods.

Revenue Composition and Diversification
Product sales remain the primary driver of total revenue, though service sales have demonstrated more consistent linear growth. Services revenue increased from 3,587 million USD in March 2021 to 6,311 million USD by March 2026, indicating a strategic shift toward higher-recurring revenue streams. The reliance on product sales, while still dominant, is marginally offset by the expanding services portfolio.
Gross Profitability and Margin Volatility
Gross margins generally expanded over the analyzed period, rising from 2,714 million USD in early 2021 to 4,594 million USD by March 2026. A critical anomaly occurred in September 2023, where gross margin plummeted to 714 million USD, coinciding with a sharp drop in product sales. Subsequent quarters show a robust recovery, with gross margins stabilizing above 4,000 million USD starting in December 2023.
Operating Efficiency and Expense Trends
Operating profit shows a general upward trend, peaking at 2,555 million USD in March 2026. Research and development expenses remained relatively stable, fluctuating between 589 million USD and 810 million USD, suggesting a disciplined approach to innovation spending relative to revenue growth. Selling, general, and administrative expenses also remained controlled, typically ranging between 1,200 million USD and 1,600 million USD, which contributed to operating leverage as sales increased.
Net Income and Bottom-Line Performance
Net income attributable to common shareholders reflects significant volatility but an overall positive slope. The period was marked by a severe net loss of 984 million USD in September 2023 and a sharp dip to 111 million USD in June 2024. However, the recovery was substantial, with net income reaching 2,059 million USD by March 2026. This suggests that while the organization is susceptible to periodic quarterly shocks, its fundamental earning capacity has strengthened over the five-year span.
Financial Obligations and Other Income
Interest expenses have trended upward, moving from approximately 346 million USD in 2021 to a range between 390 million USD and 496 million USD in later years, indicating an increase in the cost of debt or higher leverage. Other income and non-operating items have been inconsistent, periodically impacting the transition from operating profit to pre-tax income.

AI Ask an analyst for more